HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B.

AuthorsWon-Mook Choi, Jonggi Choi, Grace Lai-Hung Wong, Seungbong Han, Young-Suk Lim
JournalThe lancet. Gastroenterology & hepatology (Lancet Gastroenterol Hepatol) Vol. 6 Issue 2 Pg. 87 (02 2021) ISSN: 2468-1253 [Electronic] Netherlands
PMID33444532 (Publication Type: Letter, Comment)
Chemical References
  • Antiviral Agents
  • entecavir
  • Guanine
  • Tenofovir
Topics
  • Antiviral Agents (adverse effects)
  • Carcinoma, Hepatocellular (chemically induced, drug therapy, epidemiology)
  • Guanine (analogs & derivatives)
  • Hepatitis B, Chronic (drug therapy)
  • Humans
  • Incidence
  • Liver Neoplasms (chemically induced, drug therapy)
  • Tenofovir (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: